Health-related quality of life and other clinical outcome assessments in brain tumor patients: challenges in the design, conduct and interpretation of clinical trials

Affiliations

¹ VU University Medical Center, Department of Neurology , Amsterdam , Netherlands (L.D., M.J.B.T.); The University of Texas Health Science Center at Houston, School of Nursing, Department of Family Health , Houston, Texas (T.S.A.); The University of Texas M.D. Anderson Cancer Center, Department of Neuro-Oncology, Houston, Texas (T.S.A.); Medical Center Haaglanden, Department of Neurology, The Hague , Netherlands (M.J.B.T.).

Linda Dirven et al. Neurooncol Pract. 2015 Mar.

. 2015 Mar;2(1):2-5.

doi: 10.1093/nop/npv002.

¹ VU University Medical Center, Department of Neurology , Amsterdam , Netherlands (L.D., M.J.B.T.); The University of Texas Health Science Center at Houston, School of Nursing, Department of Family Health , Houston, Texas (T.S.A.); The University of Texas M.D. Anderson Cancer Center, Department of Neuro-Oncology, Houston, Texas (T.S.A.); Medical Center Haaglanden, Department of Neurology, The Hague , Netherlands (M.J.B.T.).

No abstract available

References

1. Patient-Centered Outcomes Research Definition. Patient-Centered Outcomes Research Institute (PCORI) 2012. http://www.pcori.org/assets/PCOR-Definition-Revised-Draft-and-Responses-.... (Accessed December 10, 2014)
1. US Food and Drug Administration. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. U.S. Department of Health and Human Services Food and Drug Administration. 2009. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformati.... (Accessed December 10, 2014) - PubMed
1. Pace A, Villani V, Zucchella C, et al. Quality of life of brain tumor patients. European Association of NeuroOncology Magazine. 2012;2:118–122.
1. Dirven L, Reijneveld JC, Taphoorn MJ. Health-related quality of life or quantity of life: a difficult trade-off in primary brain tumors? Semin Oncol. 2014;41:541–552. - PubMed
1. Osoba D. Rationale for the timing of health-related quality-of-life (HQL) assessments in oncological palliative therapy. Cancer Treat Rev. 1996;22(Suppl A):69–73. - PubMed